Overview

A Comparative Study of FV-100 vs. Valacyclovir for the Prevention of Post-Herpetic Neuralgia

Status:
Terminated
Trial end date:
2017-11-01
Target enrollment:
Participant gender:
Summary
This is a multicenter, randomized, double-blind, parallel-group, active controlled comparative study of the safety and efficacy of 2 dosing regimens of FV-100 versus valacyclovir administered for 7 days in subjects with uncomplicated AHZ(acute herpes zoster).
Phase:
Phase 3
Details
Lead Sponsor:
ContraVir Pharmaceuticals, Inc.
Treatments:
Acyclovir
Antiviral Agents
Valacyclovir